Free Trial

Alliance Pharma (APH) Competitors

Alliance Pharma logo
GBX 61.10 +0.10 (+0.16%)
As of 05:12 AM Eastern

APH vs. SPI, RTN, ESP, IPF, SGM, MSI, BERI, MCP, AMAT, and STM

Should you be buying Alliance Pharma stock or one of its competitors? The main competitors of Alliance Pharma include Spire Healthcare Group (SPI), The Restaurant Group (RTN), Empiric Student Property (ESP), International Personal Finance (IPF), Sigma Capital Group (SGM), MS INTERNATIONAL (MSI), BlackRock Energy and Resources (BERI), Martin Currie Asia Unconstrand Trust (MCP), Amati AIM VCT (AMAT), and STM Group (STM). These companies are all part of the "electronic equipment" industry.

Alliance Pharma vs.

Spire Healthcare Group (LON:SPI) and Alliance Pharma (LON:APH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, community ranking, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

50.4% of Spire Healthcare Group shares are owned by institutional investors. Comparatively, 66.3% of Alliance Pharma shares are owned by institutional investors. 34.7% of Spire Healthcare Group shares are owned by insiders. Comparatively, 12.0% of Alliance Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Spire Healthcare Group currently has a consensus target price of GBX 322, indicating a potential upside of 37.02%. Alliance Pharma has a consensus target price of GBX 60, indicating a potential downside of 1.64%. Given Spire Healthcare Group's higher probable upside, analysts plainly believe Spire Healthcare Group is more favorable than Alliance Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Alliance Pharma
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Spire Healthcare Group pays an annual dividend of GBX 3 per share and has a dividend yield of 1.3%. Alliance Pharma pays an annual dividend of GBX 2 per share and has a dividend yield of 3.3%. Spire Healthcare Group pays out 4,285.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Alliance Pharma pays out -3,333.3% of its earnings in the form of a dividend. Alliance Pharma is clearly the better dividend stock, given its higher yield and lower payout ratio.

Spire Healthcare Group has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, Alliance Pharma has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.

In the previous week, Spire Healthcare Group had 2 more articles in the media than Alliance Pharma. MarketBeat recorded 3 mentions for Spire Healthcare Group and 1 mentions for Alliance Pharma. Spire Healthcare Group's average media sentiment score of 0.00 equaled Alliance Pharma'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Spire Healthcare Group
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alliance Pharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Spire Healthcare Group received 152 more outperform votes than Alliance Pharma when rated by MarketBeat users. However, 62.08% of users gave Alliance Pharma an outperform vote while only 60.89% of users gave Spire Healthcare Group an outperform vote.

CompanyUnderperformOutperform
Spire Healthcare GroupOutperform Votes
355
60.89%
Underperform Votes
228
39.11%
Alliance PharmaOutperform Votes
203
62.08%
Underperform Votes
124
37.92%

Spire Healthcare Group has higher revenue and earnings than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spire Healthcare Group£1.44B0.66£28.30M£0.073,357.14
Alliance Pharma£183.15M1.80-£33.58M-£0.06-1,016.67

Spire Healthcare Group has a net margin of 1.96% compared to Alliance Pharma's net margin of -18.34%. Spire Healthcare Group's return on equity of 4.00% beat Alliance Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Spire Healthcare Group1.96% 4.00% 3.73%
Alliance Pharma -18.34%-13.44%5.98%

Summary

Spire Healthcare Group beats Alliance Pharma on 12 of the 18 factors compared between the two stocks.

Get Alliance Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APH vs. The Competition

MetricAlliance PharmaDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£329.75M£1.17B£5.21B£2.03B
Dividend Yield3.75%3.04%5.13%5.16%
P/E Ratio-1,016.67130.9089.341,927.11
Price / Sales1.802,866.551,240.04421,310.89
Price / Cash7.8710.2543.7529.19
Price / Book1.493.225.313.07
Net Income-£33.58M£152.21M£122.54M£183.47M
7 Day Performance-0.30%-0.24%0.59%2.98%
1 Month Performance32.68%3.34%2.55%3.31%
1 Year Performance65.99%101.86%25.29%165.23%

Alliance Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APH
Alliance Pharma
0.8037 of 5 stars
GBX 61.10
+0.2%
GBX 60
-1.8%
+66.0%£330.29M£183.15M-1,018.3391,000
SPI
Spire Healthcare Group
2.1805 of 5 stars
GBX 226
+0.7%
GBX 322
+42.5%
+4.4%£912.63M£1.44B3,228.57420News Coverage
RTN
The Restaurant Group
N/AN/AN/AN/A£499.23M£927M-1,080.0064,000
ESP
Empiric Student Property
N/AGBX 80.50
+0.8%
N/A-12.6%£485.83M£81.60M894.44150
IPF
International Personal Finance
N/AGBX 128
-1.2%
N/A+12.2%£279.22M£759.50M640.006,230
SGM
Sigma Capital Group
N/AN/AN/AN/A£181.35M£10.60M54.5948,300
MSI
MS INTERNATIONAL
N/AGBX 960
-1.0%
N/A+8.8%£153.50M£109.58M1,432.84455Insider Trade
BERI
BlackRock Energy and Resources
N/AGBX 122
+1.7%
N/A+20.9%£148.95M£27.41M677.78N/A
MCP
Martin Currie Asia Unconstrand Trust
N/AN/AN/AN/A£145.58M£6.14M43.1321,000
AMAT
Amati AIM VCT
N/AGBX 71.01
-0.7%
N/A-17.9%£104.76M£-8,000,000.00-1,014.4333,000
STM
STM Group
N/AN/AN/AN/A£35.53M£30.06M3,075.0048,300

Related Companies and Tools


This page (LON:APH) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners